JP2014531436A5 - - Google Patents

Download PDF

Info

Publication number
JP2014531436A5
JP2014531436A5 JP2014529985A JP2014529985A JP2014531436A5 JP 2014531436 A5 JP2014531436 A5 JP 2014531436A5 JP 2014529985 A JP2014529985 A JP 2014529985A JP 2014529985 A JP2014529985 A JP 2014529985A JP 2014531436 A5 JP2014531436 A5 JP 2014531436A5
Authority
JP
Japan
Prior art keywords
atoms
cancer
hal
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014529985A
Other languages
English (en)
Japanese (ja)
Other versions
JP5964974B2 (ja
JP2014531436A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/054900 external-priority patent/WO2013040059A1/en
Publication of JP2014531436A publication Critical patent/JP2014531436A/ja
Publication of JP2014531436A5 publication Critical patent/JP2014531436A5/ja
Application granted granted Critical
Publication of JP5964974B2 publication Critical patent/JP5964974B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014529985A 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとしての新規イミダゾールアミン Expired - Fee Related JP5964974B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161533601P 2011-09-12 2011-09-12
US61/533,601 2011-09-12
PCT/US2012/054900 WO2013040059A1 (en) 2011-09-12 2012-09-12 Novel imidazole amines as modulators of kinase activity

Publications (3)

Publication Number Publication Date
JP2014531436A JP2014531436A (ja) 2014-11-27
JP2014531436A5 true JP2014531436A5 (enExample) 2016-06-09
JP5964974B2 JP5964974B2 (ja) 2016-08-03

Family

ID=46881179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014529985A Expired - Fee Related JP5964974B2 (ja) 2011-09-12 2012-09-12 キナーゼ活性のモジュレーターとしての新規イミダゾールアミン

Country Status (24)

Country Link
US (2) US9145392B2 (enExample)
EP (1) EP2755965B1 (enExample)
JP (1) JP5964974B2 (enExample)
KR (1) KR101995605B1 (enExample)
CN (1) CN104080782B (enExample)
AU (1) AU2012308696B2 (enExample)
BR (1) BR112014005554A2 (enExample)
CA (1) CA2844830C (enExample)
DK (1) DK2755965T3 (enExample)
EA (1) EA025098B1 (enExample)
ES (1) ES2644536T3 (enExample)
HR (1) HRP20171554T1 (enExample)
HU (1) HUE035019T2 (enExample)
IL (1) IL231383A (enExample)
LT (1) LT2755965T (enExample)
MX (1) MX346095B (enExample)
NO (1) NO2791461T3 (enExample)
PL (1) PL2755965T3 (enExample)
PT (1) PT2755965T (enExample)
RS (1) RS56534B1 (enExample)
SG (2) SG10201606301YA (enExample)
SI (1) SI2755965T1 (enExample)
WO (1) WO2013040059A1 (enExample)
ZA (1) ZA201401013B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2646759T3 (es) * 2011-09-12 2017-12-15 Merck Patent Gmbh Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa
GEP201706623B (en) 2012-10-16 2017-02-10 Almirall Sa Pyrrolotriazinone derivatives as pi3k inhibitors
AR093511A1 (es) 2012-11-16 2015-06-10 Merck Patent Gmbh Derivados de imidazol-piperidinilo como moduladores de la actividad de cinasas
MX370448B (es) * 2013-03-11 2019-12-13 Merck Patent Gmbh Derivados de 6- [4- (1h-imidazol-2-il) piperidin-1-il] pirimidin-4-amina como moduladores de la actividad de cinasa.
JP6560243B2 (ja) * 2014-02-11 2019-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung キナーゼ活性のモジュレーターとしてのピリミジンイミダゾールアミン
WO2015159938A1 (ja) 2014-04-18 2015-10-22 武田薬品工業株式会社 複素環化合物
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
KR20200093159A (ko) 2019-01-28 2020-08-05 주식회사 링크모션 스마트 팜 모듈 구조물
PH12022551379A1 (en) 2019-12-06 2023-05-03 Vertex Pharma Substituted tetrahydrofurans as modulators of sodium channels
US11866421B2 (en) 2021-05-31 2024-01-09 Epigen Biosciences, Inc. Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
CN117567435A (zh) * 2022-01-30 2024-02-20 上海市第十人民医院 谷氨酰胺环化酶抑制剂及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
US7547794B2 (en) 2003-04-03 2009-06-16 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
US7189729B2 (en) 2003-09-30 2007-03-13 Irm Llc Methods and compositions as protein kinase inhibitors
US7816353B2 (en) 2003-10-24 2010-10-19 Exelixis, Inc. P70S6 kinase modulators and method of use
RU2006121646A (ru) 2003-11-21 2008-01-10 Новартис АГ (CH) Производные 1h-имидазохинолина в качестве ингибиторов протеинкиназы
BRPI0417498A (pt) 2003-12-09 2007-05-29 Us Gov Health & Human Serv método para suprimir uma resposta imune em um indivìduo; método de inibição da proliferação de um célula; método de tratamento de um distúrbio proliferativo em um indivìduo; método para selecionar um agente imunossupressor ou anti-proliferativo; composição farmacêutica e estente vascular
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
AU2005322085B2 (en) 2004-12-28 2012-07-19 Exelixis, Inc. [1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
EP1838703A2 (en) * 2005-01-19 2007-10-03 Neurogen Corporation Heteroaryl substituted piperazinyl-pyridine analogues
GB0501999D0 (en) 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
US8343953B2 (en) 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
UA99284C2 (ru) 2007-05-11 2012-08-10 Елі Ліллі Енд Компані ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR074072A1 (es) 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
KR101699991B1 (ko) 2009-02-11 2017-01-26 메르크 파텐트 게엠베하 신규의 아미노 아자헤테로시클릭 카르복사미드
UA110113C2 (xx) 2010-07-29 2015-11-25 Біциклічні азагетероциклічні карбоксаміди
US9586938B2 (en) 2010-07-29 2017-03-07 Merck Patent Gmbh Cyclic amine azaheterocyclic carboxamides
EA023821B1 (ru) 2010-11-24 2016-07-29 Мерк Патент Гмбх Хиназолинкарбоксамидазетидины, их применение в лечении гиперпролиферативных заболеваний и содержащие их композиции

Similar Documents

Publication Publication Date Title
JP2014527082A5 (enExample)
JP2022520811A5 (enExample)
JP2022520448A5 (enExample)
JP2019533694A5 (enExample)
JP6078639B2 (ja) Abl1、abl2およびbcr−abl1の活性を阻害するためのベンズアミド誘導体
IL295799A (en) Trophomyosin receptor kinase (trk) degradation compounds and methods of use
HRP20171554T1 (hr) Novi imidazol amini kao modulatori aktivnosti kinaze
JP2017510555A5 (enExample)
EP2810937B1 (en) Pyridone derivative
JP2017510554A5 (enExample)
JP2023514872A5 (enExample)
JP2015526519A5 (enExample)
JP2008528467A5 (enExample)
JP2013523814A5 (enExample)
JP2016525076A5 (enExample)
JP2016513660A5 (enExample)
EA032609B1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
JP2016527238A5 (enExample)
JP2009542608A5 (enExample)
JP2007500177A5 (enExample)
JP2018515492A5 (enExample)
RU2011153788A (ru) Гетероциклические противовирусные соединения
HRP20171655T1 (hr) Derivati aminopirimidina za upotrebu kao modulatori aktivnosti kinaze
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
JP2015500862A5 (enExample)